Morpholino

MO1-ap1s1

ID
ZDB-MRPHLNO-090323-1
Name
MO1-ap1s1
Previous Names
None
Target
Sequence
5' - ACAGAAGCATAAAGCGCATCATTTC - 3'
Disclaimer
Although ZFIN verifies reagent sequence data, we recommend that you conduct independent sequence analysis before ordering any reagent.
Note
None
Genome Resources
None
Target Location
Genomic Features
No data available
Expression
Gene expression in Wild Types + MO1-ap1s1
No data available
Phenotype
Phenotype resulting from MO1-ap1s1
Phenotype of all Fish created by or utilizing MO1-ap1s1
Phenotype Fish Conditions Figures
caudal fin disorganized, abnormal WT + MO1-ap1s1 standard conditions Fig. 2 with image from Montpetit et al., 2008
sensory perception of touch disrupted, abnormal WT + MO1-ap1s1 standard conditions Fig. 4 with image from Montpetit et al., 2008
caudal fin basement membrane disorganized, abnormal WT + MO1-ap1s1 standard conditions Fig. 3 with image from Montpetit et al., 2008
pigmentation decreased occurrence, abnormal WT + MO1-ap1s1 standard conditions Fig. 2 with image from Montpetit et al., 2008
integument disorganized, abnormal WT + MO1-ap1s1 standard conditions Fig. 2 with image from Montpetit et al., 2008
hindbrain distended, abnormal WT + MO1-ap1s1 chemical treatment: neocuproine Fig. 5 from Ishizaki et al., 2010
larval locomotory behavior disrupted, abnormal WT + MO1-ap1s1 standard conditions Fig. 4 with image from Montpetit et al., 2008
notochord kinked, abnormal WT + MO1-ap1s1 chemical treatment: neocuproine Fig. 5 from Ishizaki et al., 2010
whole organism decreased size, abnormal WT + MO1-ap1s1 standard conditions Fig. 2 with image from Montpetit et al., 2008
melanocyte decreased pigmentation, abnormal WT + MO1-ap1s1 chemical treatment: neocuproine Fig. 5 from Ishizaki et al., 2010
spinal cord interneuron decreased amount, abnormal WT + MO1-ap1s1 standard conditions Fig. 4 with image from Montpetit et al., 2008
axon extension disrupted, abnormal WT + MO1-ap1s1 standard conditions Fig. 4 with image from Montpetit et al., 2008
caudal fin basement membrane distributed, abnormal WT + MO1-ap1s1 standard conditions Fig. 3 with image from Montpetit et al., 2008
melanocyte decreased pigmentation, abnormal WT + MO1-ap1s1 chemical treatment: neocuproine Fig. 5 from Ishizaki et al., 2010
Citations